3rd Oct 2012 07:00
Directors' DealingsDirectors Receive Shares in Lieu of Fees
London and New York, 2 October 2012- Amphion Innovations plc (the "Company") (LSE: AMP), the developer of medical and technology businesses, announces that the Company has today issued 226,083 ordinary shares, representing 0.17% of the enlarged issued share capital, to certain of its Board members as their directors' fees for the third quarter of 2012, priced at 2.675 pence, being the average of the closing mid-market price for the five days leading up to the market close on 28 September 2012. Following this issue, the directors' shareholdings in the Company are as follows:
Director | Number of New Shares | Total Shareholding | Percentage of voting rights |
R. James Macaleer | 176,083 | 23,978,945 | 17.684% |
Gerard Moufflet | 50,000 | 700,000 | 0.516% |
Director, Anthony Henfrey waived his fees for the third quarter of 2012.
Admission of the 226,083 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 8 October 2012. Following this allotment the total issued share capital of the Company will increase to 135,600,250 ordinary shares with each share holding one voting right.
For further information please contact:
Amphion Innovations
Charlie Morgan:
+1 212 210 6224
Seymour Pierce Limited
Mark Percy (Corporate Finance)
David Banks (Corporate Broking)
+44 020 7107 8000
Cardew Group
Tim Robertson
+44 020 7930 0777
Related Shares:
AMP.L